Click here to get full coverage on Director Nathan Fountain sells 6,400 Acumen (ABOS) shares at ~$2.23 - Stock Titan

Director Nathan Fountain sells 6,400 Acumen (ABOS) shares at ~$2.23  Stock Titan

Director Nathan Fountain sells 6,400 Acumen (ABOS) shares at ~$2.23 - Stock Titan

Click here to get full coverage on Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Click here to get full coverage on [144] Acumen Pharmaceuticals, Inc. SEC Filing - Stock Titan

[144] Acumen Pharmaceuticals, Inc. SEC Filing  Stock Titan

[144] Acumen Pharmaceuticals, Inc. SEC Filing - Stock Titan

Click here to get full coverage on ACUMEN PHARMACEUTICALS ($ABOS) Releases Q4 2025 Earnings | ABOS Stock News - Quiver Quantitative

ACUMEN PHARMACEUTICALS ($ABOS) Releases Q4 2025 Earnings | ABOS Stock News  Quiver Quantitative

ACUMEN PHARMACEUTICALS ($ABOS) Releases Q4 2025 Earnings | ABOS Stock News - Quiver Quantitative

Click here to get full coverage on Acumen’s Late-2026 Sabirnetug Readout Is A Viable Bet (NASDAQ:ABOS) - Seeking Alpha

Acumen’s Late-2026 Sabirnetug Readout Is A Viable Bet (NASDAQ:ABOS)  Seeking Alpha

Acumen’s Late-2026 Sabirnetug Readout Is A Viable Bet (NASDAQ:ABOS) - Seeking Alpha

Click here to get full coverage on ABOS - Finviz

ABOS - Finviz

Click here to get full coverage on Insights from ABOS President Charles Nelson, MD - Penn Medicine

Insights from ABOS President Charles Nelson, MD  Penn Medicine

Insights from ABOS President Charles Nelson, MD - Penn Medicine

Click here to get full coverage on Sarah Abo celebrates upcoming arrival of baby boy with intimate baby shower photos - Nine.com.au

Sarah Abo celebrates upcoming arrival of baby boy with intimate baby shower photos  Nine.com.au

Sarah Abo celebrates upcoming arrival of baby boy with intimate baby shower photos - Nine.com.au

Click here to get full coverage on Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner  Yahoo Finance

Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Click here to get full coverage on $ABOS stock is down 8% today. Here's what we see in our data. - Quiver Quantitative

$ABOS stock is down 8% today. Here's what we see in our data.  Quiver Quantitative

$ABOS stock is down 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Acumen Pharmaceuticals (ABOS) grants RSUs and stock options to director - Stock Titan

Acumen Pharmaceuticals (ABOS) grants RSUs and stock options to director  Stock Titan

Acumen Pharmaceuticals (ABOS) grants RSUs and stock options to director - Stock Titan

Click here to get full coverage on Assessing Acumen Pharmaceuticals (ABOS) Valuation After New Phase 2 ALTITUDE-AD Trial Developments - Yahoo Finance

Assessing Acumen Pharmaceuticals (ABOS) Valuation After New Phase 2 ALTITUDE-AD Trial Developments  Yahoo Finance

Assessing Acumen Pharmaceuticals (ABOS) Valuation After New Phase 2 ALTITUDE-AD Trial Developments - Yahoo Finance

Click here to get full coverage on Acumen Pharmaceuticals (ABOS) director receives new RSU and option awards - Stock Titan

Acumen Pharmaceuticals (ABOS) director receives new RSU and option awards  Stock Titan

Acumen Pharmaceuticals (ABOS) director receives new RSU and option awards - Stock Titan

Click here to get full coverage on Acumen (NASDAQ: ABOS) director granted RSUs and options vesting by 2027 - Stock Titan

Acumen (NASDAQ: ABOS) director granted RSUs and options vesting by 2027  Stock Titan

Acumen (NASDAQ: ABOS) director granted RSUs and options vesting by 2027 - Stock Titan

Click here to get full coverage on Acumen Pharmaceuticals (NASDAQ: ABOS) director receives RSU and option grants - Stock Titan

Acumen Pharmaceuticals (NASDAQ: ABOS) director receives RSU and option grants  Stock Titan

Acumen Pharmaceuticals (NASDAQ: ABOS) director receives RSU and option grants - Stock Titan

Click here to get full coverage on Acumen Pharmaceuticals (NASDAQ: ABOS) director awarded RSUs and options - Stock Titan

Acumen Pharmaceuticals (NASDAQ: ABOS) director awarded RSUs and options  Stock Titan

Acumen Pharmaceuticals (NASDAQ: ABOS) director awarded RSUs and options - Stock Titan

Click here to get full coverage on Acumen Pharmaceuticals (ABOS) director receives RSU and option grants - Stock Titan

Acumen Pharmaceuticals (ABOS) director receives RSU and option grants  Stock Titan

Acumen Pharmaceuticals (ABOS) director receives RSU and option grants - Stock Titan

Click here to get full coverage on Acumen (NASDAQ: ABOS) director equity grant tied to RA Capital funds - Stock Titan

Acumen (NASDAQ: ABOS) director equity grant tied to RA Capital funds  Stock Titan

Acumen (NASDAQ: ABOS) director equity grant tied to RA Capital funds - Stock Titan

Click here to get full coverage on Acumen Pharmaceuticals (ABOS) director awarded RSUs and options for RA Capital - Stock Titan

Acumen Pharmaceuticals (ABOS) director awarded RSUs and options for RA Capital  Stock Titan

Acumen Pharmaceuticals (ABOS) director awarded RSUs and options for RA Capital - Stock Titan

Click here to get full coverage on Acumen Pharmaceuticals (NASDAQ: ABOS) investors approve equity plan and auditor - Stock Titan

Acumen Pharmaceuticals (NASDAQ: ABOS) investors approve equity plan and auditor  Stock Titan

Acumen Pharmaceuticals (NASDAQ: ABOS) investors approve equity plan and auditor - Stock Titan

Click here to get full coverage on Acumen sets May 12 earnings update, webcast starts at 8 a.m. ET - Stock Titan

Acumen sets May 12 earnings update, webcast starts at 8 a.m. ET  Stock Titan

Acumen sets May 12 earnings update, webcast starts at 8 a.m. ET - Stock Titan

Click here to get full coverage on James B. Murray Jr. discloses 3.61M shares in Acumen Pharmaceuticals (NASDAQ: ABOS) - Stock Titan

James B. Murray Jr. discloses 3.61M shares in Acumen Pharmaceuticals (NASDAQ: ABOS)  Stock Titan

James B. Murray Jr. discloses 3.61M shares in Acumen Pharmaceuticals (NASDAQ: ABOS) - Stock Titan

Click here to get full coverage on Alzheimer's drug developer Acumen sets March 26 results webcast - Stock Titan

Alzheimer's drug developer Acumen sets March 26 results webcast  Stock Titan

Alzheimer's drug developer Acumen sets March 26 results webcast - Stock Titan

Click here to get full coverage on ASCRS 2026: Carlton Yuen, MD, BSc, ABO, on dual-pump phaco fluidics and low endothelial cell loss - Ophthalmology Times

ASCRS 2026: Carlton Yuen, MD, BSc, ABO, on dual-pump phaco fluidics and low endothelial cell loss  Ophthalmology Times

ASCRS 2026: Carlton Yuen, MD, BSc, ABO, on dual-pump phaco fluidics and low endothelial cell loss - Ophthalmology Times

Click here to get full coverage on Should I buy Acumen Pharmaceuticals (ABOS) - Zacks Investment Research

Should I buy Acumen Pharmaceuticals (ABOS)  Zacks Investment Research

Should I buy Acumen Pharmaceuticals (ABOS) - Zacks Investment Research

Click here to get full coverage on What date does Acumen Pharmaceuticals's (ABOS) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

What date does Acumen Pharmaceuticals's (ABOS) report Earnings - Earnings Calendar & Announcement  Zacks Investment Research

What date does Acumen Pharmaceuticals's (ABOS) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

Click here to get full coverage on Does Sabirnetug’s Phase 2 Extension and Insider Stock Sales Alter the Bull Case for ABOS? - Yahoo Finance

Does Sabirnetug’s Phase 2 Extension and Insider Stock Sales Alter the Bull Case for ABOS?  Yahoo Finance

Does Sabirnetug’s Phase 2 Extension and Insider Stock Sales Alter the Bull Case for ABOS? - Yahoo Finance

Click here to get full coverage on Alzheimer’s brain drug: Acumen secures $35.75M after 40x uptake - Stock Titan

Alzheimer’s brain drug: Acumen secures $35.75M after 40x uptake  Stock Titan

Alzheimer’s brain drug: Acumen secures $35.75M after 40x uptake - Stock Titan

Click here to get full coverage on Acumen (ABOS) Q1 2026 Earnings Transcript - The Motley Fool

Acumen (ABOS) Q1 2026 Earnings Transcript  The Motley Fool

Acumen (ABOS) Q1 2026 Earnings Transcript - The Motley Fool

Click here to get full coverage on Alzheimer’s drug readout due in late 2026 as Acumen targets 2027 filing - Stock Titan

Alzheimer’s drug readout due in late 2026 as Acumen targets 2027 filing  Stock Titan

Alzheimer’s drug readout due in late 2026 as Acumen targets 2027 filing - Stock Titan

Click here to get full coverage on Alzheimer’s trial data slated for late 2026 as Acumen holds $128M cash - Stock Titan

Alzheimer’s trial data slated for late 2026 as Acumen holds $128M cash  Stock Titan

Alzheimer’s trial data slated for late 2026 as Acumen holds $128M cash - Stock Titan

Click here to get full coverage on Acumen executives take Bank of America health care stage May 14 - Stock Titan

Acumen executives take Bank of America health care stage May 14  Stock Titan

Acumen executives take Bank of America health care stage May 14 - Stock Titan

Click here to get full coverage on $ABOS stock is up 21% today. Here's what we see in our data. | ABOS Stock News - Quiver Quantitative

$ABOS stock is up 21% today. Here's what we see in our data. | ABOS Stock News  Quiver Quantitative

$ABOS stock is up 21% today. Here's what we see in our data. | ABOS Stock News - Quiver Quantitative

Click here to get full coverage on Insider Sale: Chief Legal Officer & Corp Sec of $ABOS Sells 15,085 Shares - Quiver Quantitative

Insider Sale: Chief Legal Officer & Corp Sec of $ABOS Sells 15,085 Shares  Quiver Quantitative

Insider Sale: Chief Legal Officer & Corp Sec of $ABOS Sells 15,085 Shares - Quiver Quantitative

Click here to get full coverage on Are Insider Tax-Related Sales Misaligned With Acumen Pharmaceuticals’ (ABOS) Alzheimer’s Trial Progress Narrative? - simplywall.st

Are Insider Tax-Related Sales Misaligned With Acumen Pharmaceuticals’ (ABOS) Alzheimer’s Trial Progress Narrative?  simplywall.st

Are Insider Tax-Related Sales Misaligned With Acumen Pharmaceuticals’ (ABOS) Alzheimer’s Trial Progress Narrative? - simplywall.st

Click here to get full coverage on “It hasn’t been an easy journey”: Sarah Abo is expecting a baby boy with husband Cyrus - The Australian Women's Weekly

“It hasn’t been an easy journey”: Sarah Abo is expecting a baby boy with husband Cyrus  The Australian Women's Weekly

“It hasn’t been an easy journey”: Sarah Abo is expecting a baby boy with husband Cyrus - The Australian Women's Weekly

Click here to get full coverage on Mouse study boosts brain delivery of Acumen’s Alzheimer’s antibody - Stock Titan

Mouse study boosts brain delivery of Acumen’s Alzheimer’s antibody  Stock Titan

Mouse study boosts brain delivery of Acumen’s Alzheimer’s antibody - Stock Titan

Click here to get full coverage on ABOS Should I Buy - Intellectia AI

ABOS Should I Buy - Intellectia AI

Click here to get full coverage on Pelopida: A recently rediscovered opera by Girolamo Abos - Festivals Malta

Pelopida: A recently rediscovered opera by Girolamo Abos  Festivals Malta

Pelopida: A recently rediscovered opera by Girolamo Abos - Festivals Malta

Click here to get full coverage on Earnings Scheduled For May 12, 2026 - Benzinga

Earnings Scheduled For May 12, 2026  Benzinga

Earnings Scheduled For May 12, 2026 - Benzinga

Click here to get full coverage on Acumen Pharma CMO Siemers sells $5.8k in ABOS stock - Investing.com

Acumen Pharma CMO Siemers sells $5.8k in ABOS stock  Investing.com

Acumen Pharma CMO Siemers sells $5.8k in ABOS stock - Investing.com

Click here to get full coverage on ABO Energy reaches international project milestones - energy-pedia.com

ABO Energy reaches international project milestones  energy-pedia.com

ABO Energy reaches international project milestones - energy-pedia.com

Click here to get full coverage on Mr. Boshra M. Abo-Saif of Park Ridge Obituary - Visitation & Funeral Information - Morizzo Funeral Home & Cremation Services

Mr. Boshra M. Abo-Saif of Park Ridge Obituary - Visitation & Funeral Information  Morizzo Funeral Home & Cremation Services

Mr. Boshra M. Abo-Saif of Park Ridge Obituary - Visitation & Funeral Information - Morizzo Funeral Home & Cremation Services

Click here to get full coverage on ABO Energy CFO leaves amid financial woes - Renewables Now

ABO Energy CFO leaves amid financial woes  Renewables Now

ABO Energy CFO leaves amid financial woes - Renewables Now

Click here to get full coverage on ABO Energy reaches key development and permitting milestones for wind projects in Germany - Energies Media

ABO Energy reaches key development and permitting milestones for wind projects in Germany  Energies Media

ABO Energy reaches key development and permitting milestones for wind projects in Germany - Energies Media

Click here to get full coverage on ABO Energy sells 63MW Canada wind project - reNEWS.BIZ

ABO Energy sells 63MW Canada wind project  reNEWS.BIZ

ABO Energy sells 63MW Canada wind project - reNEWS.BIZ

Click here to get full coverage on ABO Energy plans hydrogen plant in Nivala - Arctic Today

ABO Energy plans hydrogen plant in Nivala  Arctic Today

ABO Energy plans hydrogen plant in Nivala - Arctic Today

Click here to get full coverage on Allstate Westfield Athlete of the Week: Skylar Abo - TAPinto

Allstate Westfield Athlete of the Week: Skylar Abo  TAPinto

Allstate Westfield Athlete of the Week: Skylar Abo - TAPinto

Click here to get full coverage on Nine overlooks ‘golden girl’ for big Today gig - News.com.au

Nine overlooks ‘golden girl’ for big Today gig  News.com.au

Nine overlooks ‘golden girl’ for big Today gig - News.com.au

Click here to get full coverage on ABOS Acumen reports narrower Q4 2025 loss than consensus estimates, shares rise modestly in today’s trading. - Cổng thông tin điện tử tỉnh Lào Cai

ABOS Acumen reports narrower Q4 2025 loss than consensus estimates, shares rise modestly in today’s trading.  Cổng thông tin điện tử tỉnh Lào Cai

ABOS Acumen reports narrower Q4 2025 loss than consensus estimates, shares rise modestly in today’s trading. - Cổng thông tin điện tử tỉnh Lào Cai

Click here to get full coverage on ABO Energy Sells 85 MW Solar Projects - Mercom Capital Group

ABO Energy Sells 85 MW Solar Projects  Mercom Capital Group

ABO Energy Sells 85 MW Solar Projects - Mercom Capital Group

Click here to get full coverage on ABO Energy agrees standstill deal with creditors - Renewables Now

ABO Energy agrees standstill deal with creditors  Renewables Now

ABO Energy agrees standstill deal with creditors - Renewables Now

Click here to get full coverage on ABO bondholders back restructuring plan - reNEWS.BIZ

ABO bondholders back restructuring plan  reNEWS.BIZ

ABO bondholders back restructuring plan - reNEWS.BIZ

Click here to get full coverage on ABO Energy sees wider 2025 net loss amid lagging project sales - Renewables Now

ABO Energy sees wider 2025 net loss amid lagging project sales  Renewables Now

ABO Energy sees wider 2025 net loss amid lagging project sales - Renewables Now

Click here to get full coverage on ABO Energy sells CfD-backed solar project trio in France - Renewables Now

ABO Energy sells CfD-backed solar project trio in France  Renewables Now

ABO Energy sells CfD-backed solar project trio in France - Renewables Now

Click here to get full coverage on ABO'n waggoota 30 oliin booda filannootti deebi'uun siyaasa biyyattiif maal akeeka? - BBC

ABO'n waggoota 30 oliin booda filannootti deebi'uun siyaasa biyyattiif maal akeeka?  BBC

ABO'n waggoota 30 oliin booda filannootti deebi'uun siyaasa biyyattiif maal akeeka? - BBC

Click here to get full coverage on Olivia D’Abo, Who Played Karen on ‘The Wonder Years,’ Is 57 and Gorgeous in Rare Social Media Appearance - Parade

Olivia D’Abo, Who Played Karen on ‘The Wonder Years,’ Is 57 and Gorgeous in Rare Social Media Appearance  Parade

Olivia D’Abo, Who Played Karen on ‘The Wonder Years,’ Is 57 and Gorgeous in Rare Social Media Appearance - Parade

Click here to get full coverage on ABO Energy signs standstill pact with banks - reNEWS.BIZ

ABO Energy signs standstill pact with banks  reNEWS.BIZ

ABO Energy signs standstill pact with banks - reNEWS.BIZ

Click here to get full coverage on ABO Energy GmbH & Co. KGaA: Adjustment of the 2025 annual forecast - TradingView

ABO Energy GmbH & Co. KGaA: Adjustment of the 2025 annual forecast  TradingView

ABO Energy GmbH & Co. KGaA: Adjustment of the 2025 annual forecast - TradingView

Click here to get full coverage on Kenter elected to position of director-elect of ABOS - University of Missouri School of Medicine

Kenter elected to position of director-elect of ABOS  University of Missouri School of Medicine

Kenter elected to position of director-elect of ABOS - University of Missouri School of Medicine

Click here to get full coverage on Sarah Abo’s ‘publicity-shy’ husband: Meet the man she’s been married to for over a decade - who.com.au

Sarah Abo’s ‘publicity-shy’ husband: Meet the man she’s been married to for over a decade  who.com.au

Sarah Abo’s ‘publicity-shy’ husband: Meet the man she’s been married to for over a decade - who.com.au

Click here to get full coverage on südtirolmobil Pass: Steuerlich absetzbare Ausgaben 2025 - südtirolmobil

südtirolmobil Pass: Steuerlich absetzbare Ausgaben 2025  südtirolmobil

südtirolmobil Pass: Steuerlich absetzbare Ausgaben 2025 - südtirolmobil

Click here to get full coverage on Sarah Abo's emotional announcement - SMH.com.au

Sarah Abo's emotional announcement  SMH.com.au

Sarah Abo's emotional announcement - SMH.com.au

Click here to get full coverage on Today show host Sarah Abo announces pregnancy live on TV - SMH.com.au

Today show host Sarah Abo announces pregnancy live on TV  SMH.com.au

Today show host Sarah Abo announces pregnancy live on TV - SMH.com.au

Click here to get full coverage on Redefining Banking Intelligence with ABOS - Tata Consultancy Services

Redefining Banking Intelligence with ABOS  Tata Consultancy Services

Redefining Banking Intelligence with ABOS - Tata Consultancy Services

Click here to get full coverage on What do we really know about Sarah Abo? Inside the Today co-host’s family life - The Australian Women's Weekly

What do we really know about Sarah Abo? Inside the Today co-host’s family life  The Australian Women's Weekly

What do we really know about Sarah Abo? Inside the Today co-host’s family life - The Australian Women's Weekly

Click here to get full coverage on ABO-WBO, waa'ee hidhattoota namoota nagaarra miidhaa geessisuun himatamanii maal jedhe? - BBC

ABO-WBO, waa'ee hidhattoota namoota nagaarra miidhaa geessisuun himatamanii maal jedhe?  BBC

ABO-WBO, waa'ee hidhattoota namoota nagaarra miidhaa geessisuun himatamanii maal jedhe? - BBC

Click here to get full coverage on Addi Bilisummaa Oromoo (ABO) fi Paartiin Dimookiraatawaa Walloo (PDW) Filannoo Marsaa 7ffaaf qophii taasisuu ibsan - አዲስ ሚዲያ ኔትወርክ

Addi Bilisummaa Oromoo (ABO) fi Paartiin Dimookiraatawaa Walloo (PDW) Filannoo Marsaa 7ffaaf qophii taasisuu ibsan  አዲስ ሚዲያ ኔትወርክ

ABOS

Price Chart

Key Statistics

Technicals

About ABOS

Latest News

Director Nathan Fountain sells 6,400 Acumen (ABOS) shares at ~$2.23 - Stock Titan

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

[144] Acumen Pharmaceuticals, Inc. SEC Filing - Stock Titan

Advanced Charts

Top Gainers

Top Losers